patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Pluristem Therapeutics (PSTI) Approved To List on Nasdaq
only going to allow it to be shorted to death. We will find out next week if it is going anywhere or not. No revenue news the shorts will go nutso...JMHOFWIW
Share
New Message
Please login to post a reply